Generic orphan drug substitution: a critical analysis of global practices and Saudi Arabia’s perspective
In an era of cost pressure, substituting generic drugs represents one of the main cost-containment strategies of healthcare systems. Despite the obvious financial benefits, in a minority of cases, substitution may require caution or even be contraindicated. In most jurisdictions, to obtain approval,...
Main Authors: | Yousif S. Alakeel, Emmanouil Rampakakis, Ali AlRumaih, Rana AlRuwaisan, Maha Abushal, Abdullah M. AlDalaan, Majdy M. Idrees, Zaid D. Alanazi, Hanouf AlKoait, Abdulrahman Muaadi, Majed Ali M. AlAfra, Shaya A. AlShaya, Suliman AlHomida |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1376009/full |
Similar Items
-
Perception toward Biosimilars and Nonmedical Switching: A Cross-sectional Survey among Arab Rheumatologists
by: Mohammed A. Omair, et al.
Published: (2020-08-01) -
Factors that Influence Healthcare Professionals' Intentions towards Biosimilars
by: Mohammed Alqahtani, et al.
Published: (2024-04-01) -
IRCI‐free multiple subband MIMO SAR
by: Mohammed AlShaya, et al.
Published: (2021-07-01) -
Pharmacists’ knowledge, familiarity, and attitudes towards biosimilar drugs among practicing Jordanian pharmacists: A cross sectional study
by: Osama H. Abusara, et al.
Published: (2023-08-01) -
Comparison between Reference Infliximab (Remicade) and its Biosimilar (Remsima) in Patients with Ankylosing Spondylitis: A Field-based Pharmacoeconomic Study
by: Hasan Raid Fadhil, et al.
Published: (2023-04-01)